| |
 |
|
Class Information
Number: 424/185.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same
Description: Subject matter wherein an amino acid sequence specifying an antigen, an epitope, or another immunospecific immunoeffector is disclosed in whole or in part, wherein the disclosed amino acid sequence may be part of a conjugate, a complex, or a fusion protein or fusion polypeptide.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6495139 |
Identification and characterization of novel pneumococcal choline binding protein, CBPG, and diagnostic and therapeutic uses thereof |
Dec. 17, 2002 |
| 6495334 |
Recombinant Sef14 fimbrial protein from Salmonella |
Dec. 17, 2002 |
| 6495345 |
Surface antigen |
Dec. 17, 2002 |
| 6491920 |
Polypeptides and DNA encoding same |
Dec. 10, 2002 |
| 6488932 |
Method for treating cancer by administering MAGE-derived peptides |
Dec. 3, 2002 |
| 6488933 |
Preparations for the treatment of T cell mediated diseases |
Dec. 3, 2002 |
| 6485726 |
Receptor specific transepithelial transport of therapeutics |
Nov. 26, 2002 |
| 6482410 |
Cytotactin derivatives that stimulate attachment and neurite outgrowth, and methods of making same |
Nov. 19, 2002 |
| 6482411 |
Methods of reducing bone loss with CD40 ligand |
Nov. 19, 2002 |
| 6482412 |
Polypeptide having human HIV inhibitory activity, a gene encoding the polypeptide, a method to produce the polypeptide |
Nov. 19, 2002 |
| 6482415 |
Expression and refolding of truncated recombinant major outer membrane protein antigen (r56) of Orientia tsutsugamushi and its use in antibody based detection assays and vaccines |
Nov. 19, 2002 |
| 6475488 |
Methods of inhibiting angiogenesis and ameliorating cancer by using superfibronectin |
Nov. 5, 2002 |
| 6475491 |
Treatment of HIV and other viral infections using combinatorial therapy |
Nov. 5, 2002 |
| 6471967 |
Recombinant intracellular pathogen vaccines and methods for use |
Oct. 29, 2002 |
| 6472509 |
Feline cytokine protein |
Oct. 29, 2002 |
| 6468536 |
Use of proteins as anti-diabetes agents |
Oct. 22, 2002 |
| 6468537 |
Localization of major peptide autoepitopes for nucleosome specific T cells of systemic lupus erythematosus |
Oct. 22, 2002 |
| 6468540 |
Immunotherapeutic stress protein-peptide complexes against cancer |
Oct. 22, 2002 |
| 6468546 |
Compositions and methods for therapy and diagnosis of ovarian cancer |
Oct. 22, 2002 |
| 6464978 |
Vaccination and methods against multiple sclerosis resulting from pathogenic responses by specific T cell populations |
Oct. 15, 2002 |
| 6464980 |
MAGE-1 c-terminal immunogenic peptides |
Oct. 15, 2002 |
| 6465200 |
Transcription factor regulatory protein |
Oct. 15, 2002 |
| 6465422 |
Method for inhibiting tumor invasion or spreading in a subject |
Oct. 15, 2002 |
| 6465430 |
Peptides and compounds that bind to a thrombopoietin receptor |
Oct. 15, 2002 |
| 6465614 |
High-affinity response-selective C-terminal analogs of C5a anaphylatoxin |
Oct. 15, 2002 |
| 6461618 |
74 kilodalton outer membrane protein from moraxella catarrhalis |
Oct. 8, 2002 |
| 6458357 |
Retro-inverso neurotrophic and analgesic peptides |
Oct. 1, 2002 |
| 6458359 |
CHIMERIC GENE FORMED BY THE DNA SEQUENCES THAT ENCODE THE ANTIGENIC DETERMINANTS OF FOUR PROTEINS OF L. INFANTUM AND PROTEIN ENCODED BY SAID GENE, AND PHARMACUETICAL COMPOSITION USEFUL FOR PRE |
Oct. 1, 2002 |
| 6458366 |
Compounds and methods for diagnosis of tuberculosis |
Oct. 1, 2002 |
| 6458759 |
Compositions and methods for isolating lung surfactant hydrophobic proteins SP-B and SP-C |
Oct. 1, 2002 |
| 6458922 |
Antigens and immunoassays for diagnosing Chagas' disease |
Oct. 1, 2002 |
| 6458925 |
Peptide antagonists of zonulin and methods for use of the same |
Oct. 1, 2002 |
| 6458930 |
Aspergillus fumigatus cofilin |
Oct. 1, 2002 |
| 6455041 |
Immunogenic epitopes of the human zona pellucida protein (ZP1) |
Sep. 24, 2002 |
| 6455265 |
Method for obtaining vaccines for preventing the pathogenic effects related to a retroviral infection |
Sep. 24, 2002 |
| 6455673 |
Multi-mutant diphtheria toxin vaccines |
Sep. 24, 2002 |
| 6451303 |
Method of treating coronary artery disease by administering a recombinant FGF |
Sep. 17, 2002 |
| 6451312 |
VEGF-gelonin for targeting the vasculature of solid tumors |
Sep. 17, 2002 |
| 6451313 |
CD4-gamma2 and CD4-IGG2 chimeras |
Sep. 17, 2002 |
| 6451314 |
MHC conjugates useful in ameliorating autoimmunity |
Sep. 17, 2002 |
| 6451315 |
Compounds and methods for the diagnosis and treatment of B. microti infection |
Sep. 17, 2002 |
| 6451324 |
Ryegrass pollen allergen |
Sep. 17, 2002 |
| 6451541 |
Chaperones capable of binding to prion proteins and distinguishing the isoforms PrPc and PrPsc |
Sep. 17, 2002 |
| 6447786 |
Blocking expression of virulence factors in S. aureus |
Sep. 10, 2002 |
| 6448230 |
Testis expressed polypeptide |
Sep. 10, 2002 |
| 6448234 |
Compounds and methods for treatment and diagnosis of chlamydial infection |
Sep. 10, 2002 |
| 6448382 |
Analysis and separation of platelet-derived growth factor proteins |
Sep. 10, 2002 |
| 6444208 |
Ribonuclease III from Streptococcus pneumoniae |
Sep. 3, 2002 |
| 6444641 |
Fatty acid-acylated insulin analogs |
Sep. 3, 2002 |
| 6444644 |
Anticoagulant peptide fragments derived from apolipoprotein B-100 |
Sep. 3, 2002 |
|
|
|
